Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (9) , 1231-1238
- https://doi.org/10.1023/a:1012295131640
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung CarcinomaJournal of Clinical Oncology, 1999
- Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete RemissionNew England Journal of Medicine, 1999
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999
- Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.Journal of Clinical Oncology, 1998
- Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.Journal of Clinical Oncology, 1997
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancerAnnals of Oncology, 1994
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the LungNew England Journal of Medicine, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958